chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 89.0
Sex: F
Vaccine: COVID19-2, FLUA4
Symptoms: Asthenia, COVID-19, Chest X-ray normal, Computerised tomogram head normal, Computerised tomogram spine normal
Clinical narrative: BRIEF OVERVIEW: Admission Date: 9/4/2023 Discharge Date: Sep 6, 2023 Discharge Disposition:  home health care svc   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Weakness [R53.1] Fall, initial encounter [W19.XXXA] COVID-19 virus infection [U07.1] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 90-year-old female with a past medical history of dementia, tobacco abuse and no neck mass and left lung cavitary lesion with no plans for further workup due to advanced age and comorbidities.  She presented with a chief complaint of increased falls at her assisted living facility.  She had been fatigued and weak.  She was brought to the emergency department.  She was hemodynamically stable.  Labs were unremarkable.  Her COVID-19 was positive on PCR.  She was on room air without respiratory symptoms initially.  She did develop a mild cough.  CT head and CT cervical spine was negative for acute process.  Chest x-ray showed no acute process, but showed known left posterior perihilar mass.  She was placed in observation status for PT/OT evaluation.  PT/OT recommended skilled nursing, but it was opted to take the patient back to her assisted living facility with additional physical therapy and occupational therapy services.  She did not require Decadron or remdesivir as she was not hypoxic.  She was discharged back to her facility on 09/06/2023.
Age: 89.0
Sex: F
Vaccine: COVID19-2, FLUA4
Symptoms: Cough, Fall, Fatigue, Laboratory test normal, SARS-CoV-2 test positive
Clinical narrative: BRIEF OVERVIEW: Admission Date: 9/4/2023 Discharge Date: Sep 6, 2023 Discharge Disposition:  home health care svc   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Weakness [R53.1] Fall, initial encounter [W19.XXXA] COVID-19 virus infection [U07.1] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 90-year-old female with a past medical history of dementia, tobacco abuse and no neck mass and left lung cavitary lesion with no plans for further workup due to advanced age and comorbidities.  She presented with a chief complaint of increased falls at her assisted living facility.  She had been fatigued and weak.  She was brought to the emergency department.  She was hemodynamically stable.  Labs were unremarkable.  Her COVID-19 was positive on PCR.  She was on room air without respiratory symptoms initially.  She did develop a mild cough.  CT head and CT cervical spine was negative for acute process.  Chest x-ray showed no acute process, but showed known left posterior perihilar mass.  She was placed in observation status for PT/OT evaluation.  PT/OT recommended skilled nursing, but it was opted to take the patient back to her assisted living facility with additional physical therapy and occupational therapy services.  She did not require Decadron or remdesivir as she was not hypoxic.  She was discharged back to her facility on 09/06/2023.
Age: 80.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Asthenia, Balance disorder, Blood alkaline phosphatase increased, Blood bicarbonate normal, Blood creatinine increased
Clinical narrative: BRIEF OVERVIEW: Admission Date: 9/3/2023 Discharge Date: 09/08/2023 Discharge Disposition:  home or self care  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Sepsis [A41.9] Multiple falls [R29.6] Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE: Patient is an 81-year-old male with history of T2DM, CKD and gastric B-cell lymphoma s/p radiation and now on alkylating chemotherapy presenting following a witnessed fall from home and found to have vital sign derangements concerning for sepsis secondary to COVID-19.   Patient reported several months of functional decline with worsening generalized weakness (worse in lower extremities), balance issues, and fatigue. He has fallen several times in the last few weeks, never with loss of consciousness or severe head trauma. Timeline of symptoms is consistent with his chemotherapy regimen, which was initiated in March 2023. He has received 5 cycles of Bendamustine and Rituxan but had brief hiatus in August due to persistently low ANCs. Last cycle was two weeks ago.    On 9/3, the patient had a fall and hit the back of his head against the bathroom wall. He did not lose consciousness. Wife encouraged him to be seen in the ED. His vital signs were mildly deranged, including tachycardia around 110 and tachypnea around 23, along with one-time fever of 39.5C. blood gas demonstrating partially compensated respiratory alkalosis with pH of 7.53, CO2 of 31 calculated bicarbonate of 26. Covid-19 PCR was positive. Chemistry was remarkable for elevated BUN and creatinine, though his renal labs have been variable lately, as well as an elevated alkaline phosphatase of 189. Complete blood count demonstrated stable normocytic anemia and normal white cell count with some neutrophilic predominance by differential; however, in the setting of very low ANC last month, this was seen as an acute leukocytosis (should be noted that the patient did receive peg-filgrastim in August 2023 for leukopenia that was holding up his chemotherapy). Because of the concern for sepsis in the setting of SIRS positivity, LA was obtained and was WNL. He was admitted to the hospital for further evaluation by his oncology providers and supportive management for his COVID-19 infection.    In the inpatient setting, the patient's vitals normalized shortly after time of admission. He was stable throughout his stay, with no desaturations or oxygen requirement and minimal symptoms limited to a dry cough and persistent chronic feeling of weakness. He was evaluated by PT and OT, who recommended inpatient rehab facility transfer at time of discharge. He was also seen by Hematology/Oncology, who recommended trending CBC during admission and outpatient follow-up to discuss feasibility of continuing chemotherapy. He was discharged home in stable condition on 9/8 after finishing his course of IV remdesivir.
Age: 80.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Blood lactic acid normal, Blood pH increased, Blood urea increased, COVID-19, COVID-19 pneumonia
Clinical narrative: BRIEF OVERVIEW: Admission Date: 9/3/2023 Discharge Date: 09/08/2023 Discharge Disposition:  home or self care  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Sepsis [A41.9] Multiple falls [R29.6] Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE: Patient is an 81-year-old male with history of T2DM, CKD and gastric B-cell lymphoma s/p radiation and now on alkylating chemotherapy presenting following a witnessed fall from home and found to have vital sign derangements concerning for sepsis secondary to COVID-19.   Patient reported several months of functional decline with worsening generalized weakness (worse in lower extremities), balance issues, and fatigue. He has fallen several times in the last few weeks, never with loss of consciousness or severe head trauma. Timeline of symptoms is consistent with his chemotherapy regimen, which was initiated in March 2023. He has received 5 cycles of Bendamustine and Rituxan but had brief hiatus in August due to persistently low ANCs. Last cycle was two weeks ago.    On 9/3, the patient had a fall and hit the back of his head against the bathroom wall. He did not lose consciousness. Wife encouraged him to be seen in the ED. His vital signs were mildly deranged, including tachycardia around 110 and tachypnea around 23, along with one-time fever of 39.5C. blood gas demonstrating partially compensated respiratory alkalosis with pH of 7.53, CO2 of 31 calculated bicarbonate of 26. Covid-19 PCR was positive. Chemistry was remarkable for elevated BUN and creatinine, though his renal labs have been variable lately, as well as an elevated alkaline phosphatase of 189. Complete blood count demonstrated stable normocytic anemia and normal white cell count with some neutrophilic predominance by differential; however, in the setting of very low ANC last month, this was seen as an acute leukocytosis (should be noted that the patient did receive peg-filgrastim in August 2023 for leukopenia that was holding up his chemotherapy). Because of the concern for sepsis in the setting of SIRS positivity, LA was obtained and was WNL. He was admitted to the hospital for further evaluation by his oncology providers and supportive management for his COVID-19 infection.    In the inpatient setting, the patient's vitals normalized shortly after time of admission. He was stable throughout his stay, with no desaturations or oxygen requirement and minimal symptoms limited to a dry cough and persistent chronic feeling of weakness. He was evaluated by PT and OT, who recommended inpatient rehab facility transfer at time of discharge. He was also seen by Hematology/Oncology, who recommended trending CBC during admission and outpatient follow-up to discuss feasibility of continuing chemotherapy. He was discharged home in stable condition on 9/8 after finishing his course of IV remdesivir.
Age: 80.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Carbon dioxide increased, Cough, Fall, Fatigue, Head injury
Clinical narrative: BRIEF OVERVIEW: Admission Date: 9/3/2023 Discharge Date: 09/08/2023 Discharge Disposition:  home or self care  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Sepsis [A41.9] Multiple falls [R29.6] Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE: Patient is an 81-year-old male with history of T2DM, CKD and gastric B-cell lymphoma s/p radiation and now on alkylating chemotherapy presenting following a witnessed fall from home and found to have vital sign derangements concerning for sepsis secondary to COVID-19.   Patient reported several months of functional decline with worsening generalized weakness (worse in lower extremities), balance issues, and fatigue. He has fallen several times in the last few weeks, never with loss of consciousness or severe head trauma. Timeline of symptoms is consistent with his chemotherapy regimen, which was initiated in March 2023. He has received 5 cycles of Bendamustine and Rituxan but had brief hiatus in August due to persistently low ANCs. Last cycle was two weeks ago.    On 9/3, the patient had a fall and hit the back of his head against the bathroom wall. He did not lose consciousness. Wife encouraged him to be seen in the ED. His vital signs were mildly deranged, including tachycardia around 110 and tachypnea around 23, along with one-time fever of 39.5C. blood gas demonstrating partially compensated respiratory alkalosis with pH of 7.53, CO2 of 31 calculated bicarbonate of 26. Covid-19 PCR was positive. Chemistry was remarkable for elevated BUN and creatinine, though his renal labs have been variable lately, as well as an elevated alkaline phosphatase of 189. Complete blood count demonstrated stable normocytic anemia and normal white cell count with some neutrophilic predominance by differential; however, in the setting of very low ANC last month, this was seen as an acute leukocytosis (should be noted that the patient did receive peg-filgrastim in August 2023 for leukopenia that was holding up his chemotherapy). Because of the concern for sepsis in the setting of SIRS positivity, LA was obtained and was WNL. He was admitted to the hospital for further evaluation by his oncology providers and supportive management for his COVID-19 infection.    In the inpatient setting, the patient's vitals normalized shortly after time of admission. He was stable throughout his stay, with no desaturations or oxygen requirement and minimal symptoms limited to a dry cough and persistent chronic feeling of weakness. He was evaluated by PT and OT, who recommended inpatient rehab facility transfer at time of discharge. He was also seen by Hematology/Oncology, who recommended trending CBC during admission and outpatient follow-up to discuss feasibility of continuing chemotherapy. He was discharged home in stable condition on 9/8 after finishing his course of IV remdesivir.
Age: 80.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Leukocytosis, Leukopenia, Normocytic anaemia, Pyrexia, Renal function test abnormal
Clinical narrative: BRIEF OVERVIEW: Admission Date: 9/3/2023 Discharge Date: 09/08/2023 Discharge Disposition:  home or self care  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Sepsis [A41.9] Multiple falls [R29.6] Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE: Patient is an 81-year-old male with history of T2DM, CKD and gastric B-cell lymphoma s/p radiation and now on alkylating chemotherapy presenting following a witnessed fall from home and found to have vital sign derangements concerning for sepsis secondary to COVID-19.   Patient reported several months of functional decline with worsening generalized weakness (worse in lower extremities), balance issues, and fatigue. He has fallen several times in the last few weeks, never with loss of consciousness or severe head trauma. Timeline of symptoms is consistent with his chemotherapy regimen, which was initiated in March 2023. He has received 5 cycles of Bendamustine and Rituxan but had brief hiatus in August due to persistently low ANCs. Last cycle was two weeks ago.    On 9/3, the patient had a fall and hit the back of his head against the bathroom wall. He did not lose consciousness. Wife encouraged him to be seen in the ED. His vital signs were mildly deranged, including tachycardia around 110 and tachypnea around 23, along with one-time fever of 39.5C. blood gas demonstrating partially compensated respiratory alkalosis with pH of 7.53, CO2 of 31 calculated bicarbonate of 26. Covid-19 PCR was positive. Chemistry was remarkable for elevated BUN and creatinine, though his renal labs have been variable lately, as well as an elevated alkaline phosphatase of 189. Complete blood count demonstrated stable normocytic anemia and normal white cell count with some neutrophilic predominance by differential; however, in the setting of very low ANC last month, this was seen as an acute leukocytosis (should be noted that the patient did receive peg-filgrastim in August 2023 for leukopenia that was holding up his chemotherapy). Because of the concern for sepsis in the setting of SIRS positivity, LA was obtained and was WNL. He was admitted to the hospital for further evaluation by his oncology providers and supportive management for his COVID-19 infection.    In the inpatient setting, the patient's vitals normalized shortly after time of admission. He was stable throughout his stay, with no desaturations or oxygen requirement and minimal symptoms limited to a dry cough and persistent chronic feeling of weakness. He was evaluated by PT and OT, who recommended inpatient rehab facility transfer at time of discharge. He was also seen by Hematology/Oncology, who recommended trending CBC during admission and outpatient follow-up to discuss feasibility of continuing chemotherapy. He was discharged home in stable condition on 9/8 after finishing his course of IV remdesivir.
Age: 80.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Respiratory alkalosis, SARS-CoV-2 test positive, Sepsis, Tachycardia, Tachypnoea
Clinical narrative: BRIEF OVERVIEW: Admission Date: 9/3/2023 Discharge Date: 09/08/2023 Discharge Disposition:  home or self care  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Sepsis [A41.9] Multiple falls [R29.6] Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE: Patient is an 81-year-old male with history of T2DM, CKD and gastric B-cell lymphoma s/p radiation and now on alkylating chemotherapy presenting following a witnessed fall from home and found to have vital sign derangements concerning for sepsis secondary to COVID-19.   Patient reported several months of functional decline with worsening generalized weakness (worse in lower extremities), balance issues, and fatigue. He has fallen several times in the last few weeks, never with loss of consciousness or severe head trauma. Timeline of symptoms is consistent with his chemotherapy regimen, which was initiated in March 2023. He has received 5 cycles of Bendamustine and Rituxan but had brief hiatus in August due to persistently low ANCs. Last cycle was two weeks ago.    On 9/3, the patient had a fall and hit the back of his head against the bathroom wall. He did not lose consciousness. Wife encouraged him to be seen in the ED. His vital signs were mildly deranged, including tachycardia around 110 and tachypnea around 23, along with one-time fever of 39.5C. blood gas demonstrating partially compensated respiratory alkalosis with pH of 7.53, CO2 of 31 calculated bicarbonate of 26. Covid-19 PCR was positive. Chemistry was remarkable for elevated BUN and creatinine, though his renal labs have been variable lately, as well as an elevated alkaline phosphatase of 189. Complete blood count demonstrated stable normocytic anemia and normal white cell count with some neutrophilic predominance by differential; however, in the setting of very low ANC last month, this was seen as an acute leukocytosis (should be noted that the patient did receive peg-filgrastim in August 2023 for leukopenia that was holding up his chemotherapy). Because of the concern for sepsis in the setting of SIRS positivity, LA was obtained and was WNL. He was admitted to the hospital for further evaluation by his oncology providers and supportive management for his COVID-19 infection.    In the inpatient setting, the patient's vitals normalized shortly after time of admission. He was stable throughout his stay, with no desaturations or oxygen requirement and minimal symptoms limited to a dry cough and persistent chronic feeling of weakness. He was evaluated by PT and OT, who recommended inpatient rehab facility transfer at time of discharge. He was also seen by Hematology/Oncology, who recommended trending CBC during admission and outpatient follow-up to discuss feasibility of continuing chemotherapy. He was discharged home in stable condition on 9/8 after finishing his course of IV remdesivir.
Age: 80.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: White blood cell count normal
Clinical narrative: BRIEF OVERVIEW: Admission Date: 9/3/2023 Discharge Date: 09/08/2023 Discharge Disposition:  home or self care  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Sepsis [A41.9] Multiple falls [R29.6] Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE: Patient is an 81-year-old male with history of T2DM, CKD and gastric B-cell lymphoma s/p radiation and now on alkylating chemotherapy presenting following a witnessed fall from home and found to have vital sign derangements concerning for sepsis secondary to COVID-19.   Patient reported several months of functional decline with worsening generalized weakness (worse in lower extremities), balance issues, and fatigue. He has fallen several times in the last few weeks, never with loss of consciousness or severe head trauma. Timeline of symptoms is consistent with his chemotherapy regimen, which was initiated in March 2023. He has received 5 cycles of Bendamustine and Rituxan but had brief hiatus in August due to persistently low ANCs. Last cycle was two weeks ago.    On 9/3, the patient had a fall and hit the back of his head against the bathroom wall. He did not lose consciousness. Wife encouraged him to be seen in the ED. His vital signs were mildly deranged, including tachycardia around 110 and tachypnea around 23, along with one-time fever of 39.5C. blood gas demonstrating partially compensated respiratory alkalosis with pH of 7.53, CO2 of 31 calculated bicarbonate of 26. Covid-19 PCR was positive. Chemistry was remarkable for elevated BUN and creatinine, though his renal labs have been variable lately, as well as an elevated alkaline phosphatase of 189. Complete blood count demonstrated stable normocytic anemia and normal white cell count with some neutrophilic predominance by differential; however, in the setting of very low ANC last month, this was seen as an acute leukocytosis (should be noted that the patient did receive peg-filgrastim in August 2023 for leukopenia that was holding up his chemotherapy). Because of the concern for sepsis in the setting of SIRS positivity, LA was obtained and was WNL. He was admitted to the hospital for further evaluation by his oncology providers and supportive management for his COVID-19 infection.    In the inpatient setting, the patient's vitals normalized shortly after time of admission. He was stable throughout his stay, with no desaturations or oxygen requirement and minimal symptoms limited to a dry cough and persistent chronic feeling of weakness. He was evaluated by PT and OT, who recommended inpatient rehab facility transfer at time of discharge. He was also seen by Hematology/Oncology, who recommended trending CBC during admission and outpatient follow-up to discuss feasibility of continuing chemotherapy. He was discharged home in stable condition on 9/8 after finishing his course of IV remdesivir.
Age: 76.0
Sex: F
Vaccine: FLU4
Symptoms: Blood test, Hypoaesthesia, Injection site pain, Injection site warmth, Laboratory test
Clinical narrative: She got her vaccine, she put the shot in and didn't feel it go in.  Later on in the afternoon it got sore and had a little bit of fever in it.  The next day it was still sore.  By Friday afternoon or Saturday morning she could tell the difference in her legs.  Her legs felt like muscle pains in her legs, they were real heavy, hardly able to pick them up, felt like they weighed about 50# a piece and has had weakness in her legs.  The left foot is numb.  She did not have these issues prior to the vaccine.  She went to her doctor Tuesday 11/6/23, had blood work, and did muscle testing.  This morning she went to an UC and he also done the same tests, but did not draw any blood.  The UC doctor this morning told her to see a neurologist if her symptoms did not get better.  Her PCP told her to get some magnesium and to try that, which she got today.  They checked her levels and said that everything was OK.  She already started taking the magnesium today.
Age: 76.0
Sex: F
Vaccine: FLU4
Symptoms: Limb discomfort, Muscular weakness, Myalgia
Clinical narrative: She got her vaccine, she put the shot in and didn't feel it go in.  Later on in the afternoon it got sore and had a little bit of fever in it.  The next day it was still sore.  By Friday afternoon or Saturday morning she could tell the difference in her legs.  Her legs felt like muscle pains in her legs, they were real heavy, hardly able to pick them up, felt like they weighed about 50# a piece and has had weakness in her legs.  The left foot is numb.  She did not have these issues prior to the vaccine.  She went to her doctor Tuesday 11/6/23, had blood work, and did muscle testing.  This morning she went to an UC and he also done the same tests, but did not draw any blood.  The UC doctor this morning told her to see a neurologist if her symptoms did not get better.  Her PCP told her to get some magnesium and to try that, which she got today.  They checked her levels and said that everything was OK.  She already started taking the magnesium today.
Age: 67.0
Sex: F
Vaccine: RSV
Symptoms: Chest discomfort, Dyspnoea, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Injection site was red swollen and very sore.  Approx  7cm area.  Trouble breathing heavy chest
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cerebral atrophy, Computerised tomogram head abnormal, Confusional state, Encephalopathy
Clinical narrative: BRIEF OVERVIEW: Admission Date: 9/4/2023 Discharge Date: Sep 6, 2023 Discharge Disposition:  home or self care  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COVID-19 [U07.1]   HOSPITAL COURSE: 77 y/o male hx of GPA and ESRD on HD who presented with acute encephalopathy due to COVID 19. He was found in his restroom confused. He was brought to ED and found to be COVID positive. CT brain showed mild atrophy but no acute concerns. He was continued on his home HD schedule. His mental status quickly returned to normal. He had no residual deficits. He was able to work with physical therapy and occupational therapy and was deemed safe to return home. He was discharged to home in stable condition.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: BRIEF OVERVIEW: Admission Date: 9/4/2023 Discharge Date: Sep 6, 2023 Discharge Disposition:  home or self care  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COVID-19 [U07.1]   HOSPITAL COURSE: 77 y/o male hx of GPA and ESRD on HD who presented with acute encephalopathy due to COVID 19. He was found in his restroom confused. He was brought to ED and found to be COVID positive. CT brain showed mild atrophy but no acute concerns. He was continued on his home HD schedule. His mental status quickly returned to normal. He had no residual deficits. He was able to work with physical therapy and occupational therapy and was deemed safe to return home. He was discharged to home in stable condition.
Age: 76.0
Sex: F
Vaccine: RSV
Symptoms: Headache, Immediate post-injection reaction, Insomnia, Pain in extremity, Peripheral swelling
Clinical narrative: Immediately getting the shot, my whole arm was extremely painful. I had difficulty sleeping that night, and my arm was a little swollen.  The person gave me a flu shot the prior week and everything was perfect!  Also had a bad headache.  It is much better two days later - just a little sore.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Brain natriuretic peptide, Chest X-ray, Chest pain, Electrocardiogram, Full blood count
Clinical narrative: Chest pain, Hypotension, bilateral lower extremeties continuously shaking  Examined at ER, returned to facility 11/8/23
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension, Metabolic function test, Tremor, Troponin
Clinical narrative: Chest pain, Hypotension, bilateral lower extremeties continuously shaking  Examined at ER, returned to facility 11/8/23
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Computerised tomogram, Laboratory test
Clinical narrative: Patient to ER 11/1/23 with chest pain and diagnosed with Acute PE.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Impaired quality of life, Vulvovaginal mycotic infection
Clinical narrative: After the second shot i have been getting raging yeast infections. Green in color, and real bad in the private area. I get them every other day i have been to the dr a couple of times about this but it is nothing they can do. I cam not live a normal life anymore due to this.
Age: 3.0
Sex: M
Vaccine: DTPPVHBHPB, PNC20
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Pyrexia
Clinical narrative: Pt mom called on 11/8/23 stating her son had vaccines on Monday 11/6/23 woke up Tuesday 11/7/23 with leg hurting little swollen not wanting to walk but mom didn't think much of it at the time and gave him Motrin which got him throughout the day. Then on Wednesday 11/8/23 his leg is more swollen red and painful. Mom was concerned it may be from vaccines. Senn Dr. on 11/9/23 and per note "Swelling of left lower extremity - Fever, leg swelling and redness are most likely due to vaccines (vaxelis, PCV)  - Reassured, can use ice/cool packs, tylenol/motrin PRN - Low concern for infectious cause of rash/swelling at this point - Reviewed red flag symptoms and when to seek care - Recommended daily photo documentation in case swelling worsens"
Age: 77.0
Sex: F
Vaccine: FLU4
Symptoms: Wrong product administered
Clinical narrative: Patient requested adjuvanted flu shot and was given non-adjuvanted
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Body temperature increased, Discomfort, Heart rate increased, Productive cough
Clinical narrative: Elevated blood pressure, elevated pulse, temperature 101.5 resident reports generalized dsicomfort and chest congestion with productive cough
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory tract congestion, X-ray normal
Clinical narrative: Elevated blood pressure, elevated pulse, temperature 101.5 resident reports generalized dsicomfort and chest congestion with productive cough
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site bruising, Injection site warmth, Pain in extremity
Clinical narrative: Patient called 2 days after receiving her vaccine to report she started experiencing side effects exactly 24 hours post-vaccination.  On the night of 11.09.2023, patient noticed severe bruising at the site of injection and noticed the spot was also warm to the touch.  She said the area had a "double-quarter sized bruise."  She noted she had full mobility with her arm, but that it was still sore.  When asked if symptoms were worsening, patient said, "they were staying the same."  Patient has not contacted her doctor.
Age: 80.0
Sex: F
Vaccine: RSV, RSV
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient is a resident of a nursing home. Received an RSV vaccine on 10/11/2023 and again on 11/2/2023. As of yet, no signs or symptoms of adverse reaction.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Catheterisation cardiac normal, Chest pain, Hyperhidrosis, Supraventricular tachycardia
Clinical narrative: Patient received vaccine on Friday morning (11/3/23) at pharmacy, Saturday morning (11/4/23) patient was sweating profusely and had chest pain. She went to the ER and was admitted for 4 days for supraventricular tachycardia, cardiac catheterization was done on patient and no heart damage found, patient was finally stable and was able to leave the hospital after 4 days.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray, Dyskinesia, Full blood count, Laboratory test, Metabolic function test
Clinical narrative: Involuntayr movement/jerking of R extremities observed by staff.  Resident unresponsive to questioning by staff, only responding "Oh God."
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Unresponsive to stimuli, Urine analysis
Clinical narrative: Involuntayr movement/jerking of R extremities observed by staff.  Resident unresponsive to questioning by staff, only responding "Oh God."
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Hypoaesthesia, Vision blurred, Vomiting
Clinical narrative: vomiting, diziness, blurry vision, numbness in lower body
Age: 59.0
Sex: F
Vaccine: COVID19, VARZOS
Symptoms: Nausea, Seizure, Syncope, Tremor, Vomiting
Clinical narrative: After administering the second shot (Shingrix), the patient started shaking. Patient said she needed to lie down. Pt then lied down, put her legs up on the chair. Then the patient fainted, had a seizure for about approximately 1-2 minutes. We called 911. The patient then woke up, threw up and continued to be nauseous and throwing up. The patient started feeling better. We gave her ice pack, three small cups of water, and mint as the patient requested.
Age: 3.0
Sex: M
Vaccine: COVID19-2
Symptoms: Pallor, Rash
Clinical narrative: rash (nonurticarial, blanching, nonpruritic), lacy reticulated on extremities and face within 10 min of receiving shot. No vomiting/diarrhea/wheezing/face swelling. Provided Benadryl12.5mg/5ml, 8 ml dose x 1 with improvement but not resolution. Observed 30 min w/o worsening and sent home.
Age: 35.0
Sex: F
Vaccine: HEPA
Symptoms: Arthritis, Dizziness, Dyspnoea, Headache, Hypoaesthesia
Clinical narrative: Headache, dizziness, swelling and numbness to face and tongue, neck stiffness, neck pain, inflamed joints, body aches, feeling short of breath  Took 50mg benadryl and 800 ibuprofen initially Took 25mg Benadryl, 650mg tylenol, and 10mg flexeril 6 hours later  Numbness, swelling, and shortness of breath resolved
Age: 35.0
Sex: F
Vaccine: HEPA
Symptoms: Hypoaesthesia oral, Musculoskeletal stiffness, Neck pain, Pain, Swelling face
Clinical narrative: Headache, dizziness, swelling and numbness to face and tongue, neck stiffness, neck pain, inflamed joints, body aches, feeling short of breath  Took 50mg benadryl and 800 ibuprofen initially Took 25mg Benadryl, 650mg tylenol, and 10mg flexeril 6 hours later  Numbness, swelling, and shortness of breath resolved
Age: 35.0
Sex: F
Vaccine: HEPA
Symptoms: Swollen tongue
Clinical narrative: Headache, dizziness, swelling and numbness to face and tongue, neck stiffness, neck pain, inflamed joints, body aches, feeling short of breath  Took 50mg benadryl and 800 ibuprofen initially Took 25mg Benadryl, 650mg tylenol, and 10mg flexeril 6 hours later  Numbness, swelling, and shortness of breath resolved
Age: 0.17
Sex: M
Vaccine: HEPA
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Hepatitis A vaccine mistakenly given to 2 month old baby
Age: 69.0
Sex: M
Vaccine: UNK
Symptoms: Wrong product administered
Clinical narrative: Gave Afluria my mistake
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Brain natriuretic peptide, Metabolic function test
Clinical narrative: Elevated blood pressure 152/96 PRN clonidine 0.1 mg given x1 Lasix increased to 40 mg BID
Age: 5.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Injection site induration, Injection site inflammation, Injection site oedema, Livedo reticularis
Clinical narrative: After 24 hours inflammation at site with edematous and induration that lasted 2 weeks with residual capillary mottling that is persistent after 4 weeks
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Biopsy site unspecified abnormal, Injection site pain, Laboratory test abnormal, Lymphadenopathy, Metastases to lymph nodes
Clinical narrative: Left brachial Plexus tumor encompassing the left axillary artery; left axillary vein and the entire brachial plexus.  The tumor is unable to be separated from these main structures in the left axillary area.  Multiple lymph node involvement with metastasis to the node between the 1 and 2nd ribs of the chest.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Nervous system disorder, Oncologic complication, Pain in extremity, Peripheral nervous system neoplasm, Positron emission tomogram abnormal
Clinical narrative: Left brachial Plexus tumor encompassing the left axillary artery; left axillary vein and the entire brachial plexus.  The tumor is unable to be separated from these main structures in the left axillary area.  Multiple lymph node involvement with metastasis to the node between the 1 and 2nd ribs of the chest.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Soft tissue neoplasm
Clinical narrative: Left brachial Plexus tumor encompassing the left axillary artery; left axillary vein and the entire brachial plexus.  The tumor is unable to be separated from these main structures in the left axillary area.  Multiple lymph node involvement with metastasis to the node between the 1 and 2nd ribs of the chest.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Cerebrovascular accident, Dyskinesia, Hypoaesthesia, Mental status changes
Clinical narrative: Elevated BP 224/140 Pulse 115 altered mental status Resident approached nurse in hallway saying "I believe i'm having a stroke". Sent to ER Upon EMS arrival, Residents BP: 252/150, HR: 118. Resident unable to lift right arm, stated "her legs were numb", unable to feel pressure when put on right foot. When asked to smile, resident was unable to smile Medical Center reports resident has suffered a CVA
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased
Clinical narrative: Elevated BP 224/140 Pulse 115 altered mental status Resident approached nurse in hallway saying "I believe i'm having a stroke". Sent to ER Upon EMS arrival, Residents BP: 252/150, HR: 118. Resident unable to lift right arm, stated "her legs were numb", unable to feel pressure when put on right foot. When asked to smile, resident was unable to smile Medical Center reports resident has suffered a CVA
Age: 71.0
Sex: M
Vaccine: RSV
Symptoms: Injection site discomfort, Joint range of motion decreased
Clinical narrative: No issues with injection, some minor discomfort at the injection site over the next 2 days, then noted loss of range of motion when scratching my back, which has continued for the past month.  I have continued try daily self directed PT, without any progress.
Age: 79.0
Sex: F
Vaccine: VARZOS
Symptoms: Death, Malaise
Clinical narrative: She passed away the next evening. She stated that she was feeling unwell and I encouraged her to go to bed and rest. A while later I noticed our bathroom light was still on which was odd, I went to turn it off and saw her on the toilet. It looked like she had fallen asleep on the toilet. After getting closer to her I realized that she had died. No autopsy was done as she was given for scientific research.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose increased
Clinical narrative: High blood sugar levels for 2 days starting the day after injection. Beyond normal Novolog insulin correction levels.
Age: 42.0
Sex: F
Vaccine: COVID19, FLUC4
Symptoms: Arthralgia, Chills, Headache, Nausea, Syncope
Clinical narrative: Pt had a syncopal event 12 hours after her flu and COVID vaccines were administered at her local pharmacy.  She has had flu and COVID vaccines in the past (previous Pfizer for COVID) but not on the same day in the past. She was able to get up and get back in bed.  Endorses some HA, neck ache, chills, and nausea, which have since resolved.
Age: 68.0
Sex: M
Vaccine: FLU4
Symptoms: Pain
Clinical narrative: FOLLOWING THE VACCINATION, PATIENT REPORTED A PAIN THAT DID NOT RESOLVE WITH MEDICATIONS (IBUPROFEN AND HYDROCODONE). PATIENT REPORTED TO THE PHARMACY ON 11/10/23 TO COMPLAIN ABOUT THE PAIN THAT DID NOT RESOLVE.
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Death, Heart sounds abnormal, Pulse absent
Clinical narrative: 11/8/23 @ 22:15 resident was administered routine dose of pain medication 11/9/23 @ 06:22 Resident noted to be without heart tones and pulse. No signs of life present. Resident pronounced deceased  Death unexpected/unanticipated
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure fluctuation, Chest pain, Seizure
Clinical narrative: 11/8/23 @ 22:15 resident was administered routine dose of pain medication 11/9/23 @ 06:22 Resident noted to be without heart tones and pulse. No signs of life present. Resident pronounced deceased  Death unexpected/unanticipated
Age: 21.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against and then tested positive for COVID 19.
Age: 65.0
Sex: F
Vaccine: FLUA4, PNC20, RSV
Symptoms: Injection site erythema, Injection site oedema, Injection site pain
Clinical narrative: Possible cellulitis.  Red area from injection site into the bicep with some fluid.  Patient went to acute care and was given an antibiotic - doxycycline.  Injection was given 10/30/2023.  Reaction occurred 11/4/2023.  Patient went to acute care 11/4/2023 and started on antibiotic.  11/10/23 patient said symptoms are resolving.  She said it is still a little tender to touch.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Fatigue, Pain
Clinical narrative: Resident reported weakness, chills, bodyaches, fatigue BP 139/70 Pulse 85 Resp rate 30 Sent to ER for evaluation, admitted to Medical Center
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No known reaction.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against and then tested positive for COVID 19.
Age: 28.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site rash, Rash, Rash pruritic
Clinical narrative: pt called next day and says she has a rash around injection site and onto her back. Rash is irregularly shaped, itchy . Pt was told to start an antihistamine and follow up if worsening.
Age: 26.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction, Arteriogram coronary abnormal, C-reactive protein increased, Diuretic therapy, Echocardiogram
Clinical narrative: Myopericarditis - still hospitalized, so outcomes not yet known.  Patient is being treated with a beta-blocker, ACE-I, loop diuretic, and colchicine.
Age: 26.0
Sex: M
Vaccine: COVID19-2
Symptoms: Echocardiogram abnormal, Ejection fraction decreased, Electrocardiogram ST segment elevation, Left ventricular end-diastolic pressure decreased, Myopericarditis
Clinical narrative: Myopericarditis - still hospitalized, so outcomes not yet known.  Patient is being treated with a beta-blocker, ACE-I, loop diuretic, and colchicine.
Age: 26.0
Sex: M
Vaccine: COVID19-2
Symptoms: N-terminal prohormone brain natriuretic peptide increased, Red blood cell sedimentation rate increased, Troponin I increased
Clinical narrative: Myopericarditis - still hospitalized, so outcomes not yet known.  Patient is being treated with a beta-blocker, ACE-I, loop diuretic, and colchicine.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Chills, Headache, Nausea, Vomiting
Clinical narrative: Headache, nausea, chills, vomiting on same day/night of vaccination. Vomiting was severe and occurred repeatedly, resulting in bile coming up. Headache, nausea and vomiting ended within 24 hours of vaccination. Chest tightness/discomfort over following days continuing into Friday (three days later). No treatment, doctors office was fully booked for day during attempted visit.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Death, Dyskinesia
Clinical narrative: Approximately 35.5 hours post vaccine administration, nursing was called to Resident's room due to "jerking movements" observed by staff.  At that time, VS were taken.  T 101.2, 88% O2 on RA, 74/45, 54 bpm, and 24 RR.  Resident did not recover, and was pronounced deceased at 0730 am.  Resident had previously received Pfizer on 1/12/21, 2/05/21, and 1/04/22.  This was her fist Moderna manufactured COVID vaccine.  She received this 2023-2024 updated Spikevax vaccination on the evening of 11/07/23.
Age: 71.0
Sex: M
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: Patient claims that after one week, he developed a rash that required the purchase of $170+ in medication to make him cough the vaccine out of his body.  The patient did not contact a physician.
Age: 19.0
Sex: F
Vaccine: FLU4
Symptoms: Peripheral swelling, SARS-CoV-2 test positive
Clinical narrative: swelling of right arm , was given Prevnar right arm
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Immediate post-injection reaction, Injection site discomfort, Injection site erythema, Injection site mass
Clinical narrative: Patient came in 2 days after injection and stated she developed a lump with redness around it a day after the vaccination. They adverse reaction was not at the injection site. It is located approximately 3 to 4 inches below the injection site.  She also stated that at the time of vaccination, it felt like there were metal pieces also being injected. The vaccine was a prefilled syringe (Moderna's Spikevax). I advised the patient to mark the borders of the redness and to follow up with her physician if it continues to get worse.
Age: 75.0
Sex: F
Vaccine: FLUA4
Symptoms: Extra dose administered
Clinical narrative: AFTER VACCINATION AT PHARMACY IT WAS DISCOVERED SHE HAD RECEIVED THE INFLUENZA VACCINE AT HER PRIMARY PROVIDERS OFFICE ON 10/30/2023
Age: 88.0
Sex: M
Vaccine: COVID19-2
Symptoms: Dysphonia, Mental disorder, Mobility decreased, Neurological symptom, Speech disorder
Clinical narrative: 10 hours after shot given he started having symptoms similar to his stroke. Not able to get his feet to move. A couple hours later he started having mental problems wondering if his dead mother was there. Thought his wife was his sister. Became unable or unwilling to talk. Voice became like a whisper
Age: 36.0
Sex: M
Vaccine: FLU4
Symptoms: Arthralgia, Mobility decreased, Musculoskeletal stiffness, Neuralgia, Paraesthesia
Clinical narrative: Shoulder pain, difficulty moving right arm, shoulder stiffness, ulnar nerve pain, tingling in fingers
Age: 37.0
Sex: F
Vaccine: FLUC4
Symptoms: Erythema, Pruritus, Swelling, Urticaria
Clinical narrative: Employee c/o redness, swelling., itching and hives radiating to right chest area. Pt applied ice and took Benadryl.
Age: 71.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: LOCALIZED ERYTHEMA AT INJECTION SITE (MEASURING 3"X2" ON 10/27/23, 2.5"X1.5" ON 10/30/23, 1.5" X 1" ON 11/1/2023, 0.5"X0.5" ON 11/10/23). PATIENT REPORTED SORENESS AS 4 OUT OF 10 PAIN SCALE ON 10/27/23 AND DECREASING DAILY AFTER THAT.
Age: 22.0
Sex: F
Vaccine: FLU4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Staff member under the age of 65 was vaccinated with high dose Influenza vaccine.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Catheterisation cardiac abnormal, Coronary artery stenosis, Troponin increased
Clinical narrative: NSTEMI and subsequent STEMI later in the week. Not Fatal . Overall good health 2 years later.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, DTAPIPV
Symptoms: Extra dose administered
Clinical narrative: Extra dose of kinrix administered
Age: 54.0
Sex: F
Vaccine: RSV
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No adverse event, patient didn't report any abnormal side effects but was given vaccine even though only indicated 60 years or older. Patient was 54 at time shot was given
Sex: U
Vaccine: VARZOS
Symptoms: Chills, Headache, Mobility decreased, Pyrexia
Clinical narrative: headache; I am stuck in bed; fever of 101; Shivering; This non-serious case was reported by a consumer via call center representative and described the occurrence of headache in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 01-NOV-2023, the patient received the 2nd dose of Shingrix. In NOV-2023, an unknown time after receiving Shingrix, the patient experienced headache (Verbatim: headache), bedridden (Verbatim: I am stuck in bed), fever (Verbatim: fever of 101) and shivering (Verbatim: Shivering). The outcome of the headache, bedridden, fever and shivering were not resolved.   It was unknown if the reporter considered the headache, bedridden, fever and shivering to be related to Shingrix.   It was unknown if the company considered the headache, bedridden, fever and shivering to be related to Shingrix.   Additional Information: GSK Receipt Date: 02-NOV-2023 The patient was 50 plus in a great health. The day before reporting, the patient had the shingles vaccine and now he/she was stuck in bed with a fever of 101, shivering and headache. The follow up would not possible as no contact details were available.
Sex: F
Vaccine: VARZOS
Symptoms: Rash erythematous, Swelling
Clinical narrative: patient broke out in red rash; had large swelling on top of right shoulder; This non-serious case was reported by a other health professional via sales rep and described the occurrence of red rash in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose approximately 6 months ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced red rash (Verbatim: patient broke out in red rash) and swollen joints (Verbatim: had large swelling on top of right shoulder). The outcome of the red rash and swollen joints were not reported.   It was unknown if the reporter considered the red rash and swollen joints to be related to Shingrix.   It was unknown if the company considered the red rash and swollen joints to be related to Shingrix.   Additional Information: GSK Receipt Date: 02-NOV-2023 After second Shingrix shot (administered approximately 6 months after the 1st), patient broke out in red rash all over front of body and had large swelling on top of right shoulder. The reporter did not agree to follow up from GlaxoSmithKline.